NRIX - Balance Sheet - Nurix Therapeutics, Inc.

Current Liabilities	95.9 M
Accounts Payable	11.5 M
Short-Term Debt	8.01 M
Other Current Liabilities	76.4 M
Non-Current Liabilities	46.5 M
Long-Term Debt	20.3 M
Other Non-Current Liabilities	26.2 M

Millions

	Nov-2024	Nov-2023	Nov-2022	Nov-2021	Nov-2020	Nov-2019	Nov-2018
ASSETS
Cash & Cash Equivalents	110.0	54.6	64.5	80.5	119.4	34.8	25.6
Short Term Investments	499.6	233.3	244.7	215.2	161.8	2.9	13.4
Receivables	0	0	0	6.2	11.3	0	0
Inventory	0	0	(1.1)	1	0	0	0
Other Current Assets	9.8	7.6	9.3	9.4	5.9	1.6	1.6
Total Current Assets	619.4	295.5	318.4	311.1	298.4	39.4	40.7
PP&E	45.9	48.0	29.5	25.3	6.7	3.9	4.4
Intangible Assets	0	0	0	0	0	0	0
Goodwill	0	0	0	0	0	0	0
Long Term Investments	0	7.4	63.9	137.2	90.9	0.5	0.2
Other Long Term Assets	4.1	4.7	4.9	3.1	0.3	0.3	0.2
Other Assets	0	0	0	0	0	0	0
Total Assets	669.3	355.6	416.8	476.8	396.3	44.0	45.4
LIABILITIES
Accounts Payable	11.5	6.4	5.1	6.7	3.4	1.6	1.3
Short Term Debt	8.0	13.9	11.1	7.7	0	0	0
Other Current Liabilities	36.8	24.9	16.8	10.6	8.3	4.9	3.1
Total Current Liabilities	95.9	87.0	70.7	66.3	44.5	16.1	32.8
Long Term Debt	20.3	23.1	6.4	9.2	0	0	0
Deferred Tax Income	0	0	3.3	3.3	0	0	0
Other Liabilities	26.2	0	0	0	0.8	49.9	49.4
Total Liabilities	142.3	155.1	113.1	134.5	106.1	101.8	82.2
EQUITY
Common Stock	76 K	49 K	47 K	45 K	39 K	4 K	3 K
Retained Earnings	(738.8)	(545.2)	(401.3)	(220.9)	(103.7)	(60.5)	(38.8)
Other Accumulative Comprehensive Income/Loss	0.1	(0.7)	(4.3)	(0.6)	87 K	2 K	4 K
Total Equity	527.0	200.5	303.7	342.3	290.3	(57.7)	(36.8)
Total Liabilities and Equity	669.3	355.6	416.8	476.8	396.3	44.0	45.4
SHARES OUTSTANDING
Common Shares Outstanding	67.1	54.3	48.6	42.9	15.7	38.8	16.1

Free